Michael Berg
Conseiller Juridique Général chez TEARLAB CORPORATION
Profil
Michael Berg is currently the Vice President-Regulatory at TearLab Corporation, Inc. since 2006 and the President at Hemocue, Inc. since 2013.
He completed his undergraduate degree at the University of Notre Dame.
Postes actifs de Michael Berg
| Sociétés | Poste | Début |
|---|---|---|
| TEARLAB CORPORATION | Conseiller Juridique Général | 01/01/2006 |
| Hemocue, Inc. | President | 20/05/2010 |
Formation de Michael Berg
| University of Notre Dame | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
TearLab Corporation, Inc.
 TearLab Corporation, Inc. Medical SpecialtiesHealth Technology TearLab Corporation, Inc. engages in the development and marketing of a tear testing platform. Its primary product, the TearLab Osmolarity System, enables eye care practitioners to test for highly sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. It measures tear film osmolarity for the diagnosis of dry eye disease. The company was founded by Benjamin D. Sullivan in 1996 and is headquartered in Escondido, CA. | Health Technology |
| Hemocue, Inc. |
